TY  - JOUR
AU  - Conde, Esther
AU  - Rojo, Federico
AU  - Gómez, Javier
AU  - Enguita, Ana Belén
AU  - Abdulkader, Ihab
AU  - González, Ana
AU  - Lozano, Dolores
AU  - Mancheño, Nuria
AU  - Salas, Clara
AU  - Salido, Marta
AU  - Salido-Ruiz, Eduardo
AU  - de Álava, Enrique
PY  - 2021
DO  - 10.1136/jclinpath-2021-207490
UR  - http://hdl.handle.net/10668/20158
T2  - Journal of clinical pathology
AB  - The effectiveness of targeted therapies with tyrosine kinase inhibitors in non-small-cell lung cancer (NSCLC) depends on the accurate determination of the genomic status of the tumour. For this reason, molecular analyses to detect genetic...
LA  - en
KW  - diagnostic techniques and procedures
KW  - immunohistochemistry
KW  - oncogenes
KW  - Anaplastic Lymphoma Kinase
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Gene Rearrangement
KW  - Genetic Markers
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Immunohistochemistry
KW  - In Situ Hybridization, Fluorescence
KW  - Lung Neoplasms
KW  - Pathology, Molecular
KW  - Protein-Tyrosine Kinases
KW  - Proto-Oncogene Proteins
KW  - Sequence Analysis, DNA
TI  - Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing.
TY  - research article
VL  - 75
ER  -